This biopharma executive offers 4 steps for finding your voice
Coleen Glessner reflects on the pharma industry’s gender bias, what she’s learned about self-validation, and how “professional experimentation” leads to career success.
Coleen Glessner reflects on the pharma industry’s gender bias, what she’s learned about self-validation, and how “professional experimentation” leads to career success.
New books this year include a retirement how-to, the reissue of a classic entrepreneurship guide, and a look back at the California energy crisis.
Skeptics are more likely to approve of sustainable infrastructure when shown AI-enhanced images of how green cityscapes might look, research finds.
Business experts can now design, develop, and deploy IT applications on their own, without the need for robust programming skills.
Voluntary climate commitments by financial institutions aren’t having a positive impact, research finds. But banks do have time to reverse course and make progress.
Many experts and observers blamed 2022’s high inflation on the pandemic’s backlogged supply chain. New research shows that assessment is inaccurate.
Two types of platforms. And six ways things can go wrong.
Platform disruption is coming for more and more businesses. Here’s how to figure out if yours is one of them.
Make these three social agreements: Listen to be changed, call in don’t call out, and question your first assumptions.
As markets churn, ground your investing decisions with insights on mutual funds, options markets, target date funds, fintech, DeFi, and more.